Country Reports

This new issue of China Healthcare and Life Sciences Review (compiled in December 2019) provides a retrospective of the tremendous gains the Chinese healthcare industry made in 2019 while simultaneously anticipating the challenges and opportunities on the horizon in the new decade. From the steady national expansion of pilot regulatory reforms to the continuing exuberance…

See Full Report

Puerto Rico has a stronger healthcare manufacturing footprint than any other US jurisdiction or State, with 50 pharma and 30 medical device sites dotted throughout the island. This footprint represents around 30 percent of Puerto Rico’s GDP and two of its major exports. Several multinational firms are doubling down on their commitment to manufacturing on…

See Full Report

Belying its small size, the Nordic nation of Sweden punches well above its weight in scientific innovation. Nowhere is this Swedish spirit of innovation more keenly felt than in the country’s healthcare and life sciences industry. As the nation that introduced some of the most impactful healthcare inventions of the 20th century, Sweden and its…

See Full Report

Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an enviable reputation at the forefront of some of the most innovative trends shaping global healthcare today.   From artificial intelligence to blockchain, the internet of things and regenerative medicine, Taiwanese firms – with the backing of an increasingly supportive…

See Full Report

Thailand is in the midst of an economic transformation with healthcare at its heart. ASEAN’s second largest economy has implemented an ‘Industry 4.0’ policy through which it is attempting to prioritise R&D and innovation in a number of key industries, including healthcare and the life sciences.   Already a regional frontrunner in terms of the…

See Full Report

With optimism and energy pervading the Chinese healthcare landscape, actors of all stripes see new potential and opportunities on the horizon. The heterogeneity of the Chinese market, with its 31 province-level entities offering a variety of market characteristics and needs; the waves of overseas returnees repatriating decades of experience in top pharma companies and biotechs,…

See Full Report

Building on the topics covered in our March 2019 report, this latest edition of Healthcare & Life Sciences Review Spain takes a closer look at the broader Spanish life sciences value chain. With the Iberian nation enjoying an economic rebound, pharmaceutical multinationals are once again seeing Spain as a favourable investment destination, taking into account…

See Full Report

Now enjoying a period of relative political stability and with a swathe of economic reforms in the pipeline, Egypt is once more becoming one of the most favourable investment destinations in its region.   Nowhere is this trend more apparent than in healthcare. With the launch of the Universal Healthcare Act, which aims to provide…

See Full Report

Following on from our March 2019 report, this latest issue of Healthcare & Life Sciences Review France takes a closer look at the wider French life sciences value chain and the spirit of innovation and reform sweeping the nation.   A reform-minded and business-oriented administration under President Emmanuel Macron has already made significant progress, with…

See Full Report

One of the indisputable economic success stories of the last half century, South Korea now stands as the world’s 11th largest economy, with a reputation for industrial excellence and innovation. As the Korean state shifts its focus towards healthcare and the life sciences and Korean firms begin to internationalize with greater purpose, the attentions of…

See Full Report

China is the country it is impossible to ignore and now accounts for a significant share of revenues for most major multinational pharmaceutical companies. Further, any firm sincerely committed to bringing treatments to the greatest number of patients has to be active in China, whose population of 1.3 billion people makes up nearly a fifth…

See Full Report

France – under the business-minded administration of President Emmanuel Macron – has been rapidly climbing investor priority rankings in recent years.   This report examines the potential impact of a swathe of ambitious recently-approved reforms and a new mood of optimism sweeping the country. These stand to impact the entire strategic direction of the French…

See Full Report
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here